Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01896778 · ClinicalTrials.gov registry record · NA
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
A NA study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT01896778: Completed NA study, sponsored by Roswell Park Cancer Institute.
NCT01896778 is a NA study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01896778, a NA study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This randomized pilot clinical trial studies body warming in improving blood flow and oxygen delivery to tumors in patients with cancer. Heating tumor cells to several degrees above normal body temperature may kill tumor cells.
Primary Outcome
The primary analysis will be implemented using an analysis-of-covariance model for both blood flow and blood volume.
Interventions
- OTHER Laboratory Biomarker Analysis
- PROCEDURE Hyperthermia Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2013-10-04 |
| Est. Completion | 2018-02-23 |
| Phase | NA |
What the finished NCT01896778 record still lists
NCT01896778 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT01896778 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01896778 about?
NCT01896778 is a clinical study titled "Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer". This randomized pilot clinical trial studies body warming in improving blood flow and oxygen delivery to tumors in patients with cancer. Heating tumor cells to several degrees above normal body temperature may kill tumor cells.
What is the current status of trial NCT01896778?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2013-10-04. Estimated completion is 2018-02-23.
What interventions are being tested in trial NCT01896778?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Hyperthermia Treatment (PROCEDURE).
Who is sponsoring clinical trial NCT01896778?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01896778's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI